Search
Apiospora montagnei
go.drugbank.com/drugs/DB10844ApprovedApiospora montagnei is a fungus which can provoke allergic reactions. Apiospora montagnei extract is used in allergenic testing.
Phycomyces blakesleeanus
go.drugbank.com/drugs/DB10845ApprovedPhycomyces blakesleeanus is a fungus which can provoke allergic reactions. Phycomyces blakesleeanus extract is used in allergenic testing.
Sporotrichum pruinosum
go.drugbank.com/drugs/DB10846ApprovedSporotrichum pruinosum is a fungus which can provoke allergic reactions. Sporotrichum pruinosum extract is used in allergenic testing.
Stachybotrys chartarum
go.drugbank.com/drugs/DB10847ApprovedStachybotrys chartarum is a fungus which can provoke allergic reactions. Stachybotrys chartarum extract is used in allergenic testing.
Syncephalastrum racemosum
go.drugbank.com/drugs/DB10848ApprovedSyncephalastrum racemosum is a fungus which can provoke allergic reactions. Syncephalastrum racemosum extract is used in allergenic testing.
Epidermophyton floccosum
go.drugbank.com/drugs/DB10870ApprovedEpidermophyton floccosum is a fungus which can provoke allergic reactions. Epidermophyton floccosum extract is used in allergenic testing.
Pleospora betae
go.drugbank.com/drugs/DB10936ApprovedPleospora betae is a fungus which can provoke allergic reactions. Pleospora betae extract is used in allergenic testing.
Trichophyton tonsurans
go.drugbank.com/drugs/DB10970ApprovedTrichophyton tonsurans is a fungus which can provoke allergic reactions. Trichophyton tonsurans extract is used in allergenic testing.
Trichophyton verrucosum
go.drugbank.com/drugs/DB11295ApprovedTrichophyton verrucosum is a fungus which can provoke allergic reactions. Trichophyton verrucosum extract is used in allergenic testing.
Bevacizumab
go.drugbank.com/drugs/DB00112ApprovedInvestigational[A192939,A192837,A192891,A193275] VEGF plays an important role in angiogenesis, lymphangiogenesis, and tumor growth, which are all factors that contribute to its attractiveness as a therapeutic target. … [A286054] This off-label practice was formalized with the approval of Lytenava (bevacizumab-vikg in the US; bevacizumab gamma in the EU/UK), the first ophthalmic formulation of bevacizumab developed specifically
Products: ABXEDA E